DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $22,782,000 | -5.8% | 88,205 | -7.5% | 8.41% | -11.7% |
| Q2 2022 | $24,186,000 | -13.6% | 95,401 | 0.0% | 9.52% | +87.0% |
| Q1 2022 | $27,984,000 | -10.2% | 95,401 | +0.7% | 5.09% | -14.7% |
| Q4 2021 | $31,175,000 | +8.1% | 94,753 | 0.0% | 5.97% | -0.7% |
| Q3 2021 | $28,847,000 | +27.0% | 94,753 | +11.9% | 6.01% | +12.1% |
| Q2 2021 | $22,718,000 | +55.2% | 84,655 | +30.2% | 5.36% | +44.9% |
| Q1 2021 | $14,639,000 | -5.2% | 65,039 | -6.5% | 3.70% | -7.2% |
| Q4 2020 | $15,447,000 | -20.4% | 69,535 | -22.8% | 3.99% | -31.4% |
| Q3 2020 | $19,405,000 | +21.8% | 90,118 | 0.0% | 5.81% | +6.7% |
| Q2 2020 | $15,936,000 | +27.7% | 90,118 | -0.0% | 5.44% | +4.8% |
| Q1 2020 | $12,476,000 | -9.8% | 90,139 | 0.0% | 5.20% | +14.1% |
| Q4 2019 | $13,835,000 | -16.9% | 90,139 | -21.8% | 4.55% | -17.7% |
| Q3 2019 | $16,646,000 | +10.7% | 115,256 | +9.5% | 5.53% | +8.2% |
| Q2 2019 | $15,039,000 | +2.3% | 105,224 | -5.5% | 5.11% | -2.3% |
| Q1 2019 | $14,706,000 | +24.1% | 111,391 | -3.0% | 5.23% | +8.9% |
| Q4 2018 | $11,846,000 | +1.0% | 114,876 | +6.4% | 4.80% | +17.8% |
| Q3 2018 | $11,731,000 | +33.1% | 107,957 | +20.9% | 4.08% | +25.4% |
| Q2 2018 | $8,813,000 | +0.8% | 89,311 | 0.0% | 3.25% | -2.3% |
| Q1 2018 | $8,744,000 | +5.2% | 89,311 | -0.2% | 3.33% | +7.4% |
| Q4 2017 | $8,310,000 | -16.6% | 89,525 | -23.0% | 3.10% | -18.6% |
| Q3 2017 | $9,969,000 | +1.7% | 116,216 | 0.0% | 3.81% | -1.0% |
| Q2 2017 | $9,807,000 | +27.9% | 116,216 | +29.6% | 3.84% | +21.9% |
| Q1 2017 | $7,670,000 | +12.1% | 89,681 | +2.0% | 3.15% | +8.0% |
| Q4 2016 | $6,842,000 | +9.6% | 87,893 | +10.3% | 2.92% | +7.7% |
| Q3 2016 | $6,244,000 | +21.2% | 79,651 | +56.1% | 2.71% | +16.2% |
| Q2 2016 | $5,153,000 | +47.0% | 51,019 | +38.1% | 2.33% | -9.6% |
| Q1 2016 | $3,505,000 | +45.7% | 36,953 | +42.6% | 2.58% | +47.2% |
| Q4 2015 | $2,406,000 | – | 25,907 | – | 1.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |